Gabapentin and Effient drug interactions - a phase IV clinical study of FDA data
Drug interactions are reported among people who take Gabapentin and Effient. Common interactions include diarrhoea among females and myocardial infarction among males.
The phase IV clinical study analyzes what interactions people who take Gabapentin and Effient have. It is created by eHealthMe based on reports of 250 people who take Gabapentin and Effient from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
250 people who take Gabapentin and Effient together, and have interactions are studied.
What is Gabapentin?
Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 273,234 Gabapentin users for its effectiveness, alternative drugs and more.
What is Effient?
Effient has active ingredients of prasugrel hydrochloride. It is often used in stent. eHealthMe is studying from 9,113 Effient users for its effectiveness, alternative drugs and more.
Number of Gabapentin and Effient reports submitted per year:
Gabapentin and Effient drug interactions by gender *:
Gabapentin and Effient drug interactions by age *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Gabapentin and Effient?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Scarff JR, "The Potential for Somnambulism Associated with Gabapentin", The Internet Journal of Psychiatry, 2014 Jan .
Alternative drugs to, pros and cons of the 2 drugs:
Common Gabapentin and Effient interactions:
Browse all drug interactions of Gabapentin and Effient:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Gabapentin interactions:
Browse all interactions between Gabapentin and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Common Effient interactions:
Browse all interactions between Effient and drugs from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
How the study uses the data?
The study uses data from the FDA. It is based on gabapentin and prasugrel hydrochloride (the active ingredients of Gabapentin and Effient, respectively), and Gabapentin and Effient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gabapentin and Effient.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rocephin and Blood Bicarbonate Increased - 3 seconds ago
- Methotrexate and Pharyngolaryngeal Pain - 20 seconds ago
- Hypertension Aggravated and Attention Deficit Hyperactivity Disorder - 21 seconds ago
- Hypertension Aggravated and Attention Deficit/Hyperactivity Disorder - 21 seconds ago
- Glipizide and Valproic Acid drug interaction - 25 seconds ago
- Zelboraf and Rash Macular - 31 seconds ago
- Clobex and Herpes Zoster - 32 seconds ago
- Disseminated Intravascular Coagulation and drugs of ingredients of oxaprozin - 40 seconds ago
- Cardura Xl vs. Catapres-Tts-1 - 44 seconds ago
- Entacapone and Night Sweats - 45 seconds ago